Zetterberg

Sinequa Announces Ulf Zetterberg as Co-CEO to Support Accelerated Growth in AI Search

Retrieved on: 
Thursday, March 16, 2023
Software, Technology, Artificial Intelligence, Data Management, Cloud, Acquisition, Software as a service, DocuSign, Zetterberg, Bilger, Strategic planning, Automation, Knowledge, Growth, Deep learning, Intelligence, Knowledge management, AI, Management, Cryptocurrency

Enterprise Search leader Sinequa today announced the appointment of Ulf Zetterberg to Co-Chief Executive Officer.

Key Points: 
  • Enterprise Search leader Sinequa today announced the appointment of Ulf Zetterberg to Co-Chief Executive Officer.
  • During his tenure as CEO, Zetterberg oversaw the company’s rapid growth that led to Seal’s acquisition by DocuSign in May 2020.
  • Ulf Zetterberg, Co-CEO at Sinequa, commented: “Having spent the last two years with the Sinequa team serving on the board, I couldn’t be more excited about the opportunities ahead.
  • In June of 2022, Sinequa announced Neural Search , a solution that combines four deep learning language models in the Sinequa Search Cloud Platform to enable unprecedented accuracy and relevance in search results.

Quanterix Webinar: Recent Advancements in Neurodegenerative Biomarkers: Progress Towards A Diagnostic Blood Test for Alzheimer’s Disease

Retrieved on: 
Thursday, April 22, 2021
Mental health, Health, General Health, Research, Science, Pharmaceutical, Biotechnology, Biomarkers, Biology, Life sciences, Zetterberg

The discussion will be led by Quanterix Chairman, Chief Executive Officer, and President, Kevin Hrusovsky and will feature Charlotte Teunissen, Ph.D., UMC Amsterdam, and Henrik Zetterberg.

Key Points: 
  • The discussion will be led by Quanterix Chairman, Chief Executive Officer, and President, Kevin Hrusovsky and will feature Charlotte Teunissen, Ph.D., UMC Amsterdam, and Henrik Zetterberg.
  • Ph.D., University of Gothenberg.\nTo register for the webinar, visit https://www.quanterix.com/webinars/\nQuanterix is a company that\xe2\x80\x99s digitizing biomarker analysis with the goal of advancing the science of precision health.
  • The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease.
  • Forward-looking statements in this news release are based on Quanterix\xe2\x80\x99 expectations and assumptions as of the date of this press release.